Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
OPTEL Group on Track for Record Year in Asia-Pacific Pharma Sales 2021-03-11 04:18
Impact Therapeutics Announced First-Patient-Dose of Wee1 Inhibitor IMP7068 in the U.S. 2021-03-10 21:14
Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders 2021-03-10 20:18
Sihuan Pharmaceutical (0460.HK): Be a friend of time, 2021 is the year of turning point 2021-03-10 15:02
Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization 2021-03-10 08:00
Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs 2021-03-09 22:00
Alphamab Received U.S. FDA IND Clearance to Initiate A Phase II Pivotal Clinical Trial of KN046 (KN046-205,ENREACH-Thymic) in the U.S. 2021-03-09 20:00
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021 2021-03-09 16:00
Nippon Express (Malaysia) Obtains GDP Certification for Domestic Transport Services 2021-03-09 15:00
Yangtze River Pharmaceutical (Group) Co., Ltd. Won the 2021 EFQM Global Award 2021-03-09 11:19
Winhealth Pharma and Merz Collaborate on Hepa-Merz® to benefit patients with liver disease in China 2021-03-09 10:00
Entire industrial chain resources of advanced medical equipment are lining up at Medtec China 2021 2021-03-09 09:30
FASN Inhibitor ASC40 Demonstrates Positive Phase 2 Topline Clinical Results from China Cohort of Patients with NASH 2021-03-09 08:30
AMD Telemed Applauded by Frost & Sullivan for Its Modular Engage N' Solution that Supports Patient Needs by Acuity Level 2021-03-09 01:12
Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer 2021-03-08 22:00
CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application for a Clinical Trial of its PD-1/TGF-β Bifunctional Fusion Protein 2021-03-08 11:41
Adlai Nortye Announces Formation of its New Scientific Advisory Board 2021-03-08 09:00
Patients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38% 2021-03-08 08:48
Proxalutamide Phase III Clinical Trial for the Treatment of COVID-19 Patients Approved by FDA 2021-03-05 21:00
ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide 2021-03-05 20:00
1 255 256 257 258 259 412